The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Annals of the Rheumatic Diseases 70.4 (2011): S. 695-699.
- Keyword
-
-
Hautkrankheit
Dermatologie
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2011
- Creator
-
Balistreri, Epifania
Garcia-Gonzalez, Estrella
Selvi, Enrico
Akhmetshina, Alfiya
Palumbo, Katrin
Lorenzini, Sauro
Maggio, Roberta
Lucattelli, Monica
Galeazzi, Mauro
Distler, Jörg W. H.
- URN
-
urn:nbn:de:bvb:29-opus4-77863
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:50 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Balistreri, Epifania
- Garcia-Gonzalez, Estrella
- Selvi, Enrico
- Akhmetshina, Alfiya
- Palumbo, Katrin
- Lorenzini, Sauro
- Maggio, Roberta
- Lucattelli, Monica
- Galeazzi, Mauro
- Distler, Jörg W. H.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2011
Other Objects (12)
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Activation of pregnane X receptor inhibits experimental dermal fibrosis
The LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induces fibrosis
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Lung surfactant as pirfenidone vehicle for the treatment of bleomycin induced pulmonary fibrosis
Bleomycin (Mack)
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin]
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin] und Therapieexperimente mit Bleomycin im Meerschweintumormodell
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Activation of pregnane X receptor inhibits experimental dermal fibrosis
The LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induces fibrosis
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Lung surfactant as pirfenidone vehicle for the treatment of bleomycin induced pulmonary fibrosis
Bleomycin (Mack)
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin]
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin] und Therapieexperimente mit Bleomycin im Meerschweintumormodell
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Activation of pregnane X receptor inhibits experimental dermal fibrosis
The LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induces fibrosis
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Lung surfactant as pirfenidone vehicle for the treatment of bleomycin induced pulmonary fibrosis
Bleomycin (Mack)
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin]
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin] und Therapieexperimente mit Bleomycin im Meerschweintumormodell